02/21/2026
Planning a facelift? Let’s talk timing with injectables & energy treatments — based on what we know (and don’t know).
Facelift surgery is a foundational procedure for facial rejuvenation — but it doesn’t fully correct volume loss, skin quality changes, or dynamic wrinkles. That’s why many patients use:
💉 Neurotoxin
💉 Dermal filler
🧬 Biostimulators (Sculptra, Radiesse)
⚡ Energy-based devices (RF, ultrasound, lasers)
…before or after surgery.
But how does this affect surgical outcomes?
A small retrospective review published in Journal of Cosmetic Dermatology looked at 20 facelift patients with prior minimally invasive treatments:
• 100% had neurotoxin before surgery
• 90% had hyaluronic acid filler
• 55% had biostimulators
• Many resumed injectables within the first year after surgery
In this small cohort, prior injectable or energy-based treatment was not associated with increased surgical complications.
However — and this is important — the study was small, retrospective, and not designed to definitively assess safety or risk.
🔎 From a surgical planning standpoint, recently placed filler, collagen stimulation, or energy-induced tightening can temporarily alter anatomy and tissue behavior. That can make it harder to assess true laxity, volume loss, and vector needs.
For patients considering surgery within the next year, I generally recommend:
⏳ Avoid filler several months before surgery
⏳ Avoid biostimulators ideally 12 months prior
⏳ Avoid energy-based tightening treatments several months prior
Surgery should be performed on stable, natural anatomy whenever possible. Sequencing matters.
Larger prospective studies are still needed to define best practices — but thoughtful timing remains key to achieving the most predictable, natural outcome.
If surgery may be in your future, let’s plan strategically 🤍
